Devimistat in combination with intensive chemotherapy vs intensive chemotherapy alone for older patients with relapsed or refractory AML: Results of the randomized phase III ARMADA trial
Journal article published in 2024 by
Timothy S. Pardee,
Bayard L. Powell,
Richard A. Larson 
,
Joseph Maly,
Michael Keng,
Matthew Foster ,
Eun-Ji Choi ,
Heinz Sill,
Thomas Cluzeau,
Deepa Jeyakumar,
Olga Frankfurt,
Prapti Patel,
Michael Schuster,
Elisabeth Koller,
Regis Costello
and other authors.
,
Joseph Maly,
Michael Keng,
Matthew Foster ,
Eun-Ji Choi ,
Heinz Sill,
Thomas Cluzeau,
Deepa Jeyakumar,
Olga Frankfurt,
Prapti Patel,
Michael Schuster,
Elisabeth Koller,
Regis Costello
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 